| Watson Laboratories, Inc. Patent applications |
| Patent application number | Title | Published |
|---|
| 20120135940 | PHARMACEUTICAL COMPOSITIONS FOR LIPOPHILIC DRUGS - Stable solutions of lipophilic drugs, such as cyclosporin, forming a polar lipid self-emulsifying drug delivery system. The solutions can include lipophilic drugs, such as cyclosporin, dissolved in a polar lipid, such as having a C | 05-31-2012 |
| 20110174651 | Peelable Pouch for Transdermal Patch and Method for Packaging - A peelable pouch comprises a substantially flat enclosure formed by first and second opposing flexible plies. A seat extends along at least a portion of a perimeter of the opposing plies. A flat, flexible transdermal patch is disposed in the enclosure and includes a bioactive agent dissolved in a layer of adhesive. A release liner is removably attached over the layer of adhesive, with the patch and the release liner together being sufficiently resilient so as to generate a spring force when displaced out of the flat configuration. The first and the second plies each being separable along the seal and displaceable out of the flat configuration. The spring force generated by the patch and the release liner being sufficient to overcome an adhesive force created by the adhesive between the patch and one of the plies. | 07-21-2011 |
| 20110174650 | Peelable Pouch for Transdermal Patch and Method for Packaging - A peelable pouch comprises a substantially flat enclosure formed by first and second opposing flexible plies. A seat extends along at least a portion of a perimeter of the opposing plies. A flat, flexible transdermal patch is disposed in the enclosure and includes a bioactive agent dissolved in a layer of adhesive. A release liner is removably attached over the layer of adhesive, with the patch and the release liner together being sufficiently resilient so as to generate a spring force when displaced out of the flat configuration. The first and the second plies each being separable along the seal and displaceable out of the flat configuration. The spring force generated by the patch and the release liner being sufficient to overcome an adhesive force created by the adhesive between the patch and one of the plies. | 07-21-2011 |
| 20110057023 | Frangible Shipping Carton and Associated Methods - A selectively frangible shipping carton for storing and shipping goods comprises at least one side wall joining a top wall and a bottom wall. A path of weakness extends around a periphery of the carton through at least a portion of the side wall. The path of weakness enables a user to manually separate the carton into at least two portions: an upper portion including the top wall and a lower portion including the bottom wall. A pair of lines of weakness extends upwardly relative to the path of weakness and terminates at or adjacent the top wall. A grip flap defined in the side wall between the pair of lines of weakness, the grip flap being graspable by the user when separating the carton into the at least two portions. | 03-10-2011 |
| 20110046115 | Mirtazapine Solid Dosage Forms - A non-effervescent, solid dosage form containing mirtazapine, which is used to form mirtazapine pharmaceutical tablets. The dosage form contains mirtazapine, a hydrophilic component, and at least one lubricant. In some embodiments, the dosage forms contain a salivating agent. Processes for producing mirtazapine orally disintegrating tablets are also provided. | 02-24-2011 |
| 20100286630 | Method For Treating Overactive Bladders And A Device For Storage And Administration Of Topical Oxybutynin Compositions - The invention relates to a method for treating overactive bladders and a device for storing and administering non-occluded oxybutynin topical compositions. | 11-11-2010 |
| 20090101536 | Systems for Increasing Compliance with a Medicament Treatment Regime - A container for storing a medicament comprises a deformable shell including at least one blister associated therewith. A unit of medicament is stored in the at least one blister. A rupturable material is coupled over an opening of the blister, the rupturable material being configured to rupture upon dispensing of the unit of medicament from the blister. An aroma discharge system is coupled to, or over the opening of, the blister, the aroma discharge system containing an aroma generating substance. The aroma discharge system is positioned such that dispensing of the unit of medicament from the blister results in discharge of the aroma from the aroma generating substance. | 04-23-2009 |
